Connection

Co-Authors

Back to Details
This is a "connection" page, showing publications co-authored by Leo Heunks and Marcus Schultz.
Leo Heunks
Connection Strength
0.321
Marcus Schultz
  1. Imatinib in patients with severe COVID-19: a randomised, double-blind, placebo-controlled, clinical trial. Lancet Respir Med. 2021 09; 9(9):957-968.
    View in: PubMed
    Score: 0.059
  2. Updated guidance on the management of COVID-19: from an American Thoracic Society/European Respiratory Society coordinated International Task Force (29 July 2020). Eur Respir Rev. 2020 Sep 30; 29(157).
    View in: PubMed
    Score: 0.057
  3. Anti-C5a antibody IFX-1 (vilobelimab) treatment versus best supportive care for patients with severe COVID-19 (PANAMO): an exploratory, open-label, phase 2 randomised controlled trial. Lancet Rheumatol. 2020 Dec; 2(12):e764-e773.
    View in: PubMed
    Score: 0.057
  4. ERS statement on chest imaging in acute respiratory failure. Eur Respir J. 2019 09; 54(3).
    View in: PubMed
    Score: 0.053
  5. European Respiratory Society International Congress 2018: highlights from Assembly 2 on respiratory intensive care. ERJ Open Res. 2019 Feb; 5(1).
    View in: PubMed
    Score: 0.051
  6. Assembly 2: respiratory intensive care. Breathe (Sheff). 2017 Jun; 13(2):147-148.
    View in: PubMed
    Score: 0.045
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.